USPTO serial 75932468
BUPREL
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHICOSKI, JENNIFER D
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BUPREL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen S. Smith
KAREN S SMITH FLEHR HOHBACH TEST ALBRITTON & HERBERTFOUR EMBARCADERO CTR STE 3400SAN FRANCISCO, CA 94111-4187UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | buprenorphine formulation for use in the treatment of opiate overdoses and addiction | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2001 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Feb 20, 2001 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 23, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 22, 2000 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 24, 2000 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 16, 2000 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Aug 3, 2000 | DOCK | ASSIGNED TO EXAMINER | — |